Treatment of an acquired coagulopathy with recombinant activated factor VII in a damage-control patient.
作者： John B. Holcomb , Keith Hoots , Fredrick A. Moore
关键词: Damage control 、 Internal medicine 、 Surgery 、 Clinical trial 、 Recombinant DNA 、 Animal studies 、 Medicine 、 Gastroenterology 、 Activated factor VII 、 Blood transfusion 、 Coagulopathy 、 Resuscitation
摘要: Recombinant activated factor VII is commonly used for the treatment of hemophiliac patients with inhibitors and has been studied use in trauma. We report recombinant a male patient who was injured motor vehicle accident. also summarize animal studies clinical trials that have reported.
oup.com
sci-hub.se 参考文章(55)
Deborah A. Kuhls, Debra L. Malone, Robert J. McCarter, Lena M. Napolitano, Predictors of mortality in adult trauma patients: the physiologic trauma score is equivalent to the Trauma and Injury Severity Score. Journal of The American College of Surgeons. ,vol. 194, pp. 695- 704 ,(2002) , 10.1016/S1072-7515(02)01211-5
Richard P. Dutton, Maureen McCunn, Mary Hyder, Matthew D’Angelo, James O’Connor, John R. Hess, Thomas M. Scalea, Factor VIIa for correction of traumatic coagulopathy. Journal of Trauma-injury Infection and Critical Care. ,vol. 57, pp. 709- 719 ,(2004) , 10.1097/01.TA.0000140646.66852.AB
Michael F. Rotondo, David H. Zonies, THE DAMAGE CONTROL SEQUENCE AND UNDERLYING LOGIC Surgical Clinics of North America. ,vol. 77, pp. 761- 777 ,(1997) , 10.1016/S0039-6109(05)70582-X
Uri Martinowitz, Gili Kenet, Eran Segal, Jacob Luboshitz, Aharon Lubetsky, Jorgen Ingerslev, Mauricio Lynn, Recombinant activated factor VII for adjunctive hemorrhage control in trauma. Journal of Trauma-injury Infection and Critical Care. ,vol. 51, pp. 431- 439 ,(2001) , 10.1097/00005373-200109000-00002
J.R. Hess, M.J.G. Thomas, Blood use in war and disaster: lessons from the past century Transfusion. ,vol. 43, pp. 1622- 1633 ,(2003) , 10.1046/J.1537-2995.2003.00576.X
JAMES H. WUDEL, JOHN A. MORRIS, KENDLE YATES, ANGIE WILSON, SUE M. BASS, Massive transfusion: outcome in blunt trauma patients. Journal of Trauma-injury Infection and Critical Care. ,vol. 31, pp. 1- 7 ,(1991) , 10.1097/00005373-199101000-00001
DE Bernstein, L Jeffers, E Erhardtsen, KR Reddy, S Glazer, P Squiban, R Bech, U Hedner, ER Schiff, Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: A preliminary study Gastroenterology. ,vol. 113, pp. 1930- 1937 ,(1997) , 10.1016/S0016-5085(97)70013-1
E. Al Bokhari, L. Black, N. Akinwale, Osman M. Musa, Al A. Homaidhi, Al M. Fagih, Borum R. Andreasen, M. Al Douri, T. Shafi, D. Al Khudairi, Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery. Blood Coagulation & Fibrinolysis. ,vol. 11, ,(2000) , 10.1097/00001721-200004001-00023
U. Hedner, NovoSeven as a universal haemostatic agent. Blood Coagulation & Fibrinolysis. ,vol. 11, ,(2000) , 10.1097/00001721-200004001-00020
Susan R. Heckbert, Nicholas B. Vedder, Wilma Hoffman, Robert K. Winn, Leonard D. Hudson, Gregory J. Jurkovich, Michael K. Copass, John M. Harlan, Charles L. Rice, Ronald V. Maier, Outcome after Hemorrhagic Shock in Trauma Patients Journal of Trauma-injury Infection and Critical Care. ,vol. 45, pp. 545- 549 ,(1998) , 10.1097/00005373-199809000-00022